Infection rates remained low for CD4-VLPs at both concentrations, suggesting that a therapeutic that presents clusters of CD4 is more effective than traditional CD4-based inhibitors in controlling HIV-1 replication and preventing viral escape. This evidence concerns the gene CD4 and infection.